Bontempo Ohly Capital Mgmt LLC Amgen Inc Transaction History

Bontempo Ohly Capital Mgmt LLC

$208 Million
Q1 2025

A detailed history of Bontempo Ohly Capital Mgmt LLC transactions in Amgen Inc stock. As of the latest transaction made, Bontempo Ohly Capital Mgmt LLC holds 9,845 shares of AMGN stock, worth $2.81 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

9,845

Previous 8,275 18.97%

Holding current value

$2.81 Million

Previous $2.16 Million 42.25%

% of portfolio

1.48%

Previous 1.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Jun 05, 2025	BUY	$258.59 - $327.36 $405,986 - $513,955	1,570 Added 18.97%	9,845 $3.07 Million
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $40,628 - $51,544	-157 Reduced 1.86%	8,275 $2.16 Million
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $129,630 - $141,362	419 Added 5.23%	8,432 $2.72 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $7,094 - $8,621	27 Added 0.34%	8,013 $2.5 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $139,812 - $168,771	-520 Reduced 6.11%	7,986 $2.27 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $17,131 - $19,326	67 Added 0.79%	8,506 $2.45 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $218 - $271	-1 Reduced 0.01%	8,439 $2.27 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $8,570 - $10,134	-40 Reduced 0.47%	8,440 $1.87 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $245,885 - $299,692	-1,089 Reduced 11.38%	8,480 $2.05 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $38,935 - $49,471	-170 Reduced 1.75%	9,569 $2.51 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $10,100 - $11,391	-45 Reduced 0.46%	9,739 $2.2 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $21,456 - $23,876	-93 Reduced 0.94%	9,784 $2.38 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $74,551 - $82,473	340 Added 3.57%	9,877 $2.39 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $33,809 - $38,692	170 Added 1.81%	9,537 $2.15 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $7,217 - $8,455	-34 Reduced 0.36%	9,367 $1.99 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $74,979 - $83,183	-321 Reduced 3.3%	9,401 $2.29 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $2.16 Million - $2.51 Million	9,722 New	9,722 $2.42 Million

Others Institutions Holding AMGN

# of Institutions

3,271

Shares Held

445M

Call Options Held

7.23M

Put Options Held

6.71M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bontempo Ohly Capital Mgmt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bontempo Ohly Capital Mgmt LLC with notifications on news.

Account

Bontempo Ohly Capital Mgmt LLC Amgen Inc Transaction History